MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $584,913 | -37.0% | 40,311 | -17.2% | 0.01% | -43.8% |
| Q3 2022 | $929,000 | +8.8% | 48,685 | +3.6% | 0.02% | +14.3% |
| Q2 2022 | $854,000 | -32.2% | 46,991 | -6.0% | 0.01% | -22.2% |
| Q1 2022 | $1,259,000 | -7.4% | 49,977 | +1.4% | 0.02% | 0.0% |
| Q4 2021 | $1,360,000 | -16.8% | 49,290 | -2.6% | 0.02% | -21.7% |
| Q3 2021 | $1,634,000 | +6.0% | 50,619 | +0.5% | 0.02% | +4.5% |
| Q2 2021 | $1,541,000 | -17.9% | 50,386 | -18.3% | 0.02% | -24.1% |
| Q1 2021 | $1,878,000 | +70.3% | 61,669 | +10.6% | 0.03% | +61.1% |
| Q4 2020 | $1,103,000 | +80.2% | 55,780 | +18.9% | 0.02% | +50.0% |
| Q3 2020 | $612,000 | +11.5% | 46,914 | -3.0% | 0.01% | +9.1% |
| Q2 2020 | $549,000 | -22.8% | 48,388 | -2.6% | 0.01% | -35.3% |
| Q1 2020 | $711,000 | -45.0% | 49,667 | +4.6% | 0.02% | -37.0% |
| Q4 2019 | $1,293,000 | -12.5% | 47,499 | -8.0% | 0.03% | -18.2% |
| Q3 2019 | $1,478,000 | – | 51,610 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $98,875,000 | 3.47% |
| Tieton Capital Management, LLC | 187,636 | $3,711,000 | 2.72% |
| Glenview Capital Management | 3,682,691 | $72,825,000 | 1.67% |
| Altium Capital Management LP | 218,650 | $4,324,000 | 1.61% |
| S&T BANK/PA | 331,098 | $6,547,000 | 1.18% |
| EARNEST PARTNERS LLC | 6,731,429 | $133,114,000 | 0.92% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,078,075 | $41,094,000 | 0.79% |
| SummerHaven Investment Management, LLC | 35,700 | $706,000 | 0.55% |
| AIMZ Investment Advisors, LLC | 42,685 | $844,000 | 0.44% |
| CONTINENTAL ADVISORS LLC | 36,392 | $720,000 | 0.33% |